Abits Group Vs. Sarepta Therapeutics Industry Stock Comparison

Buy

87

ABTS
Abits Group

Last Price:

0.58

Seasonality Move:

0.91%

Buy

58

SRPT
Sarepta Therapeutics

Last Price:

133.49

Seasonality Move:

14.88%

Buy

87

Abits Group (ABTS) is a Buy

Is Abits Group a Buy, Sell or Hold?

The current Abits Group [ABTS] share price is $0.62. The Score for ABTS is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
ABTS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

Buy

58

Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ABTS Stock Price Chart

What is Abits Group's stock price today?

The Abits Group share price today is $0.62
The current trend is moderately bearish and ABTS is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $133.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ABTS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.03	Buy
Relative Strength Index (14 RSI):	54.42	Buy
Chaikin Money Flow:	13037	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.54 - 0.64)	Buy
Bollinger Bands (100):	(0.46 - 0.58)	Buy

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.78	Buy
Relative Strength Index (14 RSI):	63.54	Buy
Chaikin Money Flow:	-725343	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(110.85 - 129.81)	Buy
Bollinger Bands (100):	(119.21 - 141.67)	Buy

ABTS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.62	Buy
20-day SMA:	0.6	Buy
50-day SMA:	0.53	Buy
200-day SMA:	0.62	Sell
8-day EMA:	0.61	Buy
20-day EMA:	0.59	Buy
50-day EMA:	0.56	Buy
200-day EMA:	0.63	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	119.83	Buy
20-day SMA:	118.14	Buy
50-day SMA:	122.33	Buy
200-day SMA:	130.09	Buy
8-day EMA:	123.82	Buy
20-day EMA:	120.48	Buy
50-day EMA:	122.96	Buy
200-day EMA:	126.17	Buy

Abits Group Earnings Growth & ABTS Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Abits Group Technical Analysis

	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29
	Nov
	15	18	19	20	21	22	25	26	27	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29
	Nov
	15	18	19	20	21	22	25	26	27	29
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):